This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boerner, J. L.
Right arrow Articles by Parsons, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boerner, J. L.
Right arrow Articles by Parsons, S. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2004, p. 7059-7071, Vol. 24, No. 16
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.16.7059-7071.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II

Julie L. Boerner, Michelle L. Demory, Corinne Silva, and Sarah J. Parsons*

Department of Microbiology and Cancer Center at the University of Virginia Health System, Charlottesville, Virginia 22908

Received 2 July 2003/ Returned for modification 28 August 2003/ Accepted 21 May 2004

When co-overexpressed, the epidermal growth factor receptor (EGFR) and c-Src cooperate to cause synergistic increases in EGF-induced DNA synthesis, soft agar colony growth, and tumor formation in nude mice. This synergy is dependent upon c-Src-mediated phosphorylation of a unique tyrosine on the EGFR, namely, tyrosine 845 (Y845). Phenylalanine substitution of Y845 (Y845F) was found to inhibit EGF-induced DNA synthesis without affecting the catalytic activity of the receptor or its ability to phosphorylate Shc or activate mitogen-activated protein kinase. These results suggest that synergism may occur through alternate signaling pathways mediated by phosphorylated Y845 (pY845). One such pathway involves the transcription factor Stat5b. Here we describe another pathway that involves cytochrome c oxidase subunit II (CoxII). CoxII was identified as a specific binding partner of a pY845-containing peptide in a phage display screen. EGF-dependent binding of CoxII to the wild type but not to the mutant Y845F-EGFR was confirmed by coimmunoprecipitation experiments. This association also required the kinase activity of c-Src. Confocal microscopy, as well as biochemical fractionation, indicated that the EGFR translocates to the mitochondria after EGF stimulation, where it colocalizes with CoxII. Such translocation required the catalytic activity of the receptor but not phosphorylation of Y845. However, ectopic expression of the Y845F-EGFR prevented the EGF from protecting MDA-MB-231 breast cancer cells from adriamycin-induced apoptosis, whereas two mutants of Stat5b, a dominant-interfering mutant (DNstat5b) and a tyrosine mutation at 699 (Y699F-Stat5b) did not. Taken together, these data suggest that, through the ability of EGFR to translocate to the mitochondria, the binding of proteins such as CoxII to pY845 on the EGFR may positively regulate survival pathways that contribute to oncogenesis.

* Corresponding author. Mailing address: Department of Microbiology, University of Virginia, Jordan Hall 2-11, P.O. Box 800734, Charlottesville, VA 22908. Phone: (434) 924-2352. Fax: (434) 982-0689. E-mail: sap{at}virginia.edu.

Molecular and Cellular Biology, August 2004, p. 7059-7071, Vol. 24, No. 16
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.16.7059-7071.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ahsan, A., Hiniker, S. M., Davis, M. A., Lawrence, T. S., Nyati, M. K. (2009). Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated Radiosensitization. Cancer Res. 69: 5108-5114 [Abstract] [Full Text]  
  • Giaccone, G., Zucali, P. A. (2008). Src as a potential therapeutic target in non-small-cell lung cancer. Ann Oncol 19: 1219-1223 [Abstract] [Full Text]  
  • Kiley, S. C., Chevalier, R. L. (2007). Species differences in renal Src activity direct EGF receptor regulation in life or death response to EGF. Am. J. Physiol. Renal Physiol. 293: F895-F903 [Abstract] [Full Text]  
  • Pochampalli, M. R., Bitler, B. G., Schroeder, J. A. (2007). Transforming Growth Factor {alpha} Dependent Cancer Progression Is Modulated by Muc1. Cancer Res. 67: 6591-6598 [Abstract] [Full Text]  
  • Dimri, M., Naramura, M., Duan, L., Chen, J., Ortega-Cava, C., Chen, G., Goswami, R., Fernandes, N., Gao, Q., Dimri, G. P., Band, V., Band, H. (2007). Modeling Breast Cancer-Associated c-Src and EGFR Overexpression in Human MECs: c-Src and EGFR Cooperatively Promote Aberrant Three-dimensional Acinar Structure and Invasive Behavior. Cancer Res. 67: 4164-4172 [Abstract] [Full Text]  
  • Liao, H.-J., Carpenter, G. (2007). Role of the Sec61 Translocon in EGF Receptor Trafficking to the Nucleus and Gene Expression. Mol. Biol. Cell 18: 1064-1072 [Abstract] [Full Text]  
  • Riggins, R. B., Thomas, K. S., Ta, H. Q., Wen, J., Davis, R. J., Schuh, N. R., Donelan, S. S., Owen, K. A., Gibson, M. A., Shupnik, M. A., Silva, C. M., Parsons, S. J., Clarke, R., Bouton, A. H. (2006). Physical and Functional Interactions between Cas and c-Src Induce Tamoxifen Resistance of Breast Cancer Cells through Pathways Involving Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 5b.. Cancer Res. 66: 7007-7015 [Abstract] [Full Text]  
  • Livigni, A., Scorziello, A., Agnese, S., Adornetto, A., Carlucci, A., Garbi, C., Castaldo, I., Annunziato, L., Avvedimento, E. V., Feliciello, A. (2006). Mitochondrial AKAP121 Links cAMP and src Signaling to Oxidative Metabolism. Mol. Biol. Cell 17: 263-271 [Abstract] [Full Text]  
  • Thelemann, A., Petti, F., Griffin, G., Iwata, K., Hunt, T., Settinari, T., Fenyo, D., Gibson, N., Haley, J. D. (2005). Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells. Mol. Cell. Proteomics 4: 356-376 [Abstract] [Full Text]  
  • Lee, I., Salomon, A. R., Ficarro, S., Mathes, I., Lottspeich, F., Grossman, L. I., Huttemann, M. (2005). cAMP-dependent Tyrosine Phosphorylation of Subunit I Inhibits Cytochrome c Oxidase Activity. J. Biol. Chem. 280: 6094-6100 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»